DrugDashboards

Midazolam Hydrochloride

Midazolam Hydrochloride · MIDAZOLAM HYDROCHLORIDE 2 mg/mL · Syrup · Oral · Hikma Pharmaceuticals USA Inc.

NDC 00054-3566-99 · 118 mL in 1 BOTTLE, GLASS · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.6360 per mL over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Oct 2013Sep 2026$0.636
43 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$130.00
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$56,448
2,859 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for midazolam hydrochloride (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA075873
TE code
AA
Approval date
Apr 30, 2002
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Midazolam Hydrochloride (Syrup)

LabelerStrengthFirst seenLast seen
Precision Dose Inc.MIDAZOLAM HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
American Health PackagingMIDAZOLAM HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackMIDAZOLAM HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.MIDAZOLAM HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Padagis US LLCMIDAZOLAM HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Midazolam Hydrochloride — NDC 00054-3566-99," retrieved September 3, 2026, https://drugdashboards.com/drug/00054356699.

Free to cite with attribution — see how the data is put together.